Neurostimulation Devices | Market Insights | Europe (Supplemental) | 2021
Although it will be negatively impacted in the short term by the COVID-19 pandemic, the European neurostimulation device market is growing modestly, and will be buoyed over the forecast period by the ongoing launch of premium-priced products.
This Medtech 360 Report provides key market metrics and high-level qualitative commentary for the neurostimulation device market in Europe, including country-level data for 21 major countries and aggregate data for the rest of Europe, across a 10-year period.